Bumper Offer - Urjas oil Just @ Rs. 1
Turbovas Asp is a commercial drug that is prescribed in the form of Tablet, Capsule. Other than this, Turbovas Asp has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Turbovas Asp. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Turbovas Asp side effects, there are can be others also. These have been listed below. These side effects of Turbovas Asp are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Turbovas Asp's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Turbovas Asp's effects on the liver, heart and kidney are discussed below in the Turbovas Asp related warnings section.
Turbovas Asp can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Turbovas Asp in conditions like Kidney Disease, Hypothyroidism, Drug Allergy. The section on Turbovas Asp contraindications lists all such conditions.
Drug interactions for Turbovas Asp have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Turbovas Asp, it is important to know that it is safe while driving, and is habit-forming.
Turbovas Asp is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Turbovas Asp is used -
Severe
Moderate
Mild
Is the use of Turbovas Asp safe for pregnant women?
Pregnant women may get severe side effects after taking Turbovas Asp. If you are pregnant, do not take Turbovas Asp without a doctor's advice.
Is the use of Turbovas Asp safe during breastfeeding?
Taking Turbovas Asp may lead to serious side effects if you are breastfeeding. Turbovas Asp should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Turbovas Asp on the Kidneys?
There may be some adverse effects on kidney after taking Turbovas Asp. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Turbovas Asp on the Liver?
Using Turbovas Asp does not have any harmful effects on the liver.
What is the effect of Turbovas Asp on the Heart?
There may be an adverse effect on the heart after taking Turbovas Asp. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Turbovas Asp should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Turbovas Asp unless your doctor advises you to do so -
Is this Turbovas Asp habit forming or addictive?
Forming a habit of Turbovas Asp has not been reported.
Interaction between Food and Turbovas Asp
There isn't any research available on the side effects of taking Turbovas Asp with food.
Interaction between Alcohol and Turbovas Asp
Information about the interaction of Turbovas Asp and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194